RTI Surgical

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, RTI Surgical sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 1 currently recruiting 8 completed later-stage tilt top decile by trial count

RTI Surgical: 12 sponsored US clinical trials, 1 recruiting.

RTI Surgical sponsors 12 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 8 completed. 4 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Knee Injury, with 1 trials.

Top-decile sponsor footprint

RTI Surgical ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 21/100

8 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

12 total, page 1 of 1

RECRUITING NA

Acellular Dermal Matrix Investigation in Breast Reconstruction

NCT06456554
COMPLETED

Streamline Occipito-Cervico-Thoracic System Post-Market Clinical Follow-up

NCT04171544
COMPLETED

Evaluation of the Fortilink IBF System With TETRAfuse Technology

NCT03699891
COMPLETED

BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study

NCT00975845
COMPLETED NA

Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion

NCT02628210
COMPLETED NA

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

NCT02587403
TERMINATED Phase 4

A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft

NCT02161016
TERMINATED Phase 3

Evaluation of a Composite Cancellous and Demineralized Bone Plug (CR-Plug) for Repair of Knee Osteochondral Defects

NCT00984594
COMPLETED Phase 3

Evaluation of the CR Plug for Repair of Defects Created at the Harvest Site From an Autograft in the Knee.

NCT00821873
TERMINATED Phase 3

Evaluation of the CR Plug (Allograft) for the Treatment of a Cartilage Injury in the Knee.

NCT00793104
COMPLETED

Clinical Application of BioCleanse Meniscus

NCT00659880
COMPLETED Phase 2

Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects

NCT00255970

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 3
Phase 4 1

Therapeutic Areas

Knee Injury 1
Spondylosis 1
Spondylolisthesis 1
Breast Reconstruction 1
Ventral Hernia 1
Degenerative Disc Disease 1

Where RTI Surgical enrollment is open (later-stage tilt)

1 recruiting of 12 indexed (8% open); 8 completed (67%).

Phase mix: 4 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Knee Injury (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

RTI Surgical: open-pipeline peers nationwide

Peers matched on 12 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

RTI Surgical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10152025 0%5%10%15%20% Total trials Recruiting share RTI SurgicalAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAcrotech BiopharmaAtlanta VA Medical CenterBeacon TherapeuticsBoston VA Research Institute
RTI Surgical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

RTI Surgical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this RTI Surgical page

12 registered trials is a research-attention snapshot, not an endorsement of RTI Surgical or any single study.

  • 1 of RTI Surgical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Knee Injury is the condition RTI Surgical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Knee Injury trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

RTI Surgical pipeline card: 12 registered trials from official public datasets.Report a data error.